Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)
Boku, N., Ryu, M.-H., Kato, K., Chung, H.C., Minashi, K., Lee, K.-W., Cho, H., Kang, W.K., Komatsu, Y., Tsuda, M., Yamaguchi, K., Hara, H., Fumita, S., Azuma, M., Chen, L.-T., Kang, Y.-K.
Published in Annals of oncology (01.02.2019)
Published in Annals of oncology (01.02.2019)
Get full text
Journal Article
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
Kang, Y.-K., Kang, W.-K., Shin, D.-B., Chen, J., Xiong, J., Wang, J., Lichinitser, M., Guan, Z., Khasanov, R., Zheng, L., Philco-Salas, M., Suarez, T., Santamaria, J., Forster, G., McCloud, P. I.
Published in Annals of oncology (01.04.2009)
Published in Annals of oncology (01.04.2009)
Get full text
Journal Article
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer
Okines, A.F.C., Norman, A.R., McCloud, P., Kang, Y.-K., Cunningham, D.
Published in Annals of oncology (01.09.2009)
Published in Annals of oncology (01.09.2009)
Get full text
Journal Article
Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma
Kang, Y.-K., Yau, T., Park, J.-W., Lim, H.Y., Lee, T.-Y., Obi, S., Chan, S.L., Qin, S.K., Kim, R.D., Casey, M., Chen, C., Bhattacharyya, H., Williams, J.A., Valota, O., Chakrabarti, D., Kudo, M.
Published in Annals of oncology (01.12.2015)
Published in Annals of oncology (01.12.2015)
Get full text
Journal Article
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib
Serrano, C., Bauer, S., Gómez-Peregrina, D., Kang, Y.-K., Jones, R.L., Rutkowski, P., Mir, O., Heinrich, M.C., Tap, W.D., Newberry, K., Grassian, A., Shi, H., Bialick, S., Schöffski, P., Pantaleo, M.A., von Mehren, M., Trent, J.C., George, S.
Published in Annals of oncology (01.07.2023)
Published in Annals of oncology (01.07.2023)
Get full text
Journal Article
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody–drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation study
Gazzah, A., Bedard, P.L., Hierro, C., Kang, Y.-K., Abdul Razak, A., Ryu, M.-H., Demers, B., Fagniez, N., Henry, C., Hospitel, M., Soria, J.-C., Tabernero, J.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040
El-Khoueiry, A.B., Trojan, J., Meyer, T., Yau, T., Melero, I., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Kang, Y.-K., Yeo, W., Chopra, A., Soleymani, S., Yao, J., Neely, J., Tschaika, M., Welling, T.H., Sangro, B.
Published in Annals of oncology (01.04.2024)
Published in Annals of oncology (01.04.2024)
Get full text
Journal Article
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
Demetri, G.D., Antonescu, C.R., Bjerkehagen, B., Bovée, J.V.M.G., Boye, K., Chacón, M., Dei Tos, A.P., Desai, J., Fletcher, J.A., Gelderblom, H., George, S., Gronchi, A., Haas, R.L., Hindi, N., Hohenberger, P., Joensuu, H., Jones, R.L., Judson, I., Kang, Y.-K., Kawai, A., Lazar, A.J., Le Cesne, A., Maestro, R., Maki, R.G., Martín, J., Patel, S., Penault-Llorca, F., Premanand Raut, C., Rutkowski, P., Safwat, A., Sbaraglia, M., Schaefer, I.-M., Shen, L., Serrano, C., Schöffski, P., Stacchiotti, S., Sundby Hall, K., Tap, W.D., Thomas, D.M., Trent, J., Valverde, C., van der Graaf, W.T.A., von Mehren, M., Wagner, A., Wardelmann, E., Naito, Y., Zalcberg, J., Blay, J.-Y.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer
Bang, Y.-J., Kang, Y.-K., Ng, M., Chung, H.C., Wainberg, Z.A., Gendreau, S., Chan, W.Y., Xu, N., Maslyar, D., Meng, R., Chau, I., Ajani, J.A.
Published in European journal of cancer (1990) (01.02.2019)
Published in European journal of cancer (1990) (01.02.2019)
Get full text
Journal Article
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040
Melero, I., Yau, T., Kang, Y.-K., Kim, T.-Y., Santoro, A., Sangro, B., Kudo, M., Hou, M.-M., Matilla, A., Tovoli, F., Knox, J., He, A.R., El-Rayes, B., Acosta-Rivera, M., Lim, H.Y., Soleymani, S., Yao, J., Neely, J., Tschaika, M., Hsu, C., El-Khoueiry, A.B.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
Roy, A.C., Park, S.R., Cunningham, D., Kang, Y.K., Chao, Y., Chen, L.T., Rees, C., Lim, H.Y., Tabernero, J., Ramos, F.J., Kujundzic, M., Cardic, M.B., Yeh, C.G., de Gramont, A.
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article
Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy
Kang, Y.-K., Ryu, M.-H., Park, S.H., Kim, J.G., Kim, J.W., Cho, S.-H., Park, Y.-I., Park, S.R., Rha, S.Y., Kang, M.J., Cho, J.Y., Kang, S.Y., Roh, S.Y., Ryoo, B.-Y., Nam, B.-H., Jo, Y.-W., Yoon, K.-E., Oh, S.C.
Published in Annals of oncology (01.05.2018)
Published in Annals of oncology (01.05.2018)
Get full text
Journal Article
Analysis of serum protein biomarkers, circulating tumor DNA, and dovitinib activity in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumors
Yoo, C., Ryu, M.-H., Na, Y.S., Ryoo, B.-Y., Park, S.R., Kang, Y.-K.
Published in Annals of oncology (01.11.2014)
Published in Annals of oncology (01.11.2014)
Get full text
Journal Article
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum
YOON, D. H, RYU, M.-H, PARK, Y. S, LEE, H. J, LEE, C, RYOO, B.-Y, LEE, J.-L, CHANG, H.-M, KIM, T. W, KANG, Y.-K
Published in British journal of cancer (13.03.2012)
Published in British journal of cancer (13.03.2012)
Get full text
Journal Article
A phase III study of nivolumab (nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Two-years update data
Satoh, T., Chen, L.-T., Kang, Y.-K., Chao, Y., Kato, K., Chung, H.C., Chen, J.-S., Muro, K., Kang, W.K., Yoshikawa, T., Oh, S.C., Tamura, T., Lee, K.-W., Boku, N.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)
Ryu, M.-H., Baba, E., Lee, K.H., Park, Y.I., Boku, N., Hyodo, I., Nam, B.-H., Esaki, T., Yoo, C., Ryoo, B.-Y., Song, E.-K., Cho, S.-H., Kang, W.K., Yang, S.H., Zang, D.Y., Shin, D.B., Park, S.R., Shinozaki, K., Takano, T., Kang, Y.-K.
Published in Annals of oncology (01.10.2015)
Published in Annals of oncology (01.10.2015)
Get full text
Journal Article
Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib
KANG, Y.-K, YOO, C, RYU, M.-H, RYOO, B.-Y, LEE, J. J, TAN, E, PARK, I, PARK, J. H, CHOI, Y. J, JO, J, RYU, J.-S
Published in British journal of cancer (29.10.2013)
Published in British journal of cancer (29.10.2013)
Get full text
Journal Article
Updated results from a phase I trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with pretreated recurrent or refractory gastric cancer
Bang, Y.-J., Doi, T., Kondo, S., Chung, H.C., Muro, K., Dussault, I., Helwig, C., Osada, M., Kang, Y.-K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article